Evaluation of price disparity among generic medicines in india

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Even though the generic medicines are considered to be a cheaper option compared to the branded medicines in India, there is a need to study the price disparity among the generic medicines. Hence, the present study aims to evaluate the price disparity in generic medicines under Government Scheme in India. Methods: It was found that there were 101 generic medicines approved at a fixed price for procurement under the Central Government Health Services scheme. The prices of these medicines were searched for their availability as well as for current price in Bureau of Pharma PSUs of India (under Jan Aushadhi scheme) website. Results: The major category of the generic medicine were antibiotics (53.45%) followed by nonsteroidal anti-inflammatory drugs (10.89%) and cardiovascular (6.93%) drugs. It was evident from the result obtained by comparing the prices across categories that there were both positive and negative deviations. Conclusion: It was very much evident from the results of the mean of differences that even though fixed price contracts being in place, there is a price disparity in the generic drug prices seen under Government Scheme.

Original languageEnglish
Pages (from-to)466-468
Number of pages3
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume11
Issue number12
DOIs
Publication statusPublished - 01-12-2018

Fingerprint

India
Generic Drugs
Cardiovascular Agents
Contracts
Health Services
Anti-Inflammatory Agents
Anti-Bacterial Agents
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

@article{f35e51756d604a8296a32e1ec4e5dc71,
title = "Evaluation of price disparity among generic medicines in india",
abstract = "Objective: Even though the generic medicines are considered to be a cheaper option compared to the branded medicines in India, there is a need to study the price disparity among the generic medicines. Hence, the present study aims to evaluate the price disparity in generic medicines under Government Scheme in India. Methods: It was found that there were 101 generic medicines approved at a fixed price for procurement under the Central Government Health Services scheme. The prices of these medicines were searched for their availability as well as for current price in Bureau of Pharma PSUs of India (under Jan Aushadhi scheme) website. Results: The major category of the generic medicine were antibiotics (53.45{\%}) followed by nonsteroidal anti-inflammatory drugs (10.89{\%}) and cardiovascular (6.93{\%}) drugs. It was evident from the result obtained by comparing the prices across categories that there were both positive and negative deviations. Conclusion: It was very much evident from the results of the mean of differences that even though fixed price contracts being in place, there is a price disparity in the generic drug prices seen under Government Scheme.",
author = "Reena Shaik and Muragundi, {Pradeep M.}",
year = "2018",
month = "12",
day = "1",
doi = "10.22159/ajpcr.2018.v11i12.28461",
language = "English",
volume = "11",
pages = "466--468",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "12",

}

Evaluation of price disparity among generic medicines in india. / Shaik, Reena; Muragundi, Pradeep M.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, No. 12, 01.12.2018, p. 466-468.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of price disparity among generic medicines in india

AU - Shaik, Reena

AU - Muragundi, Pradeep M.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Objective: Even though the generic medicines are considered to be a cheaper option compared to the branded medicines in India, there is a need to study the price disparity among the generic medicines. Hence, the present study aims to evaluate the price disparity in generic medicines under Government Scheme in India. Methods: It was found that there were 101 generic medicines approved at a fixed price for procurement under the Central Government Health Services scheme. The prices of these medicines were searched for their availability as well as for current price in Bureau of Pharma PSUs of India (under Jan Aushadhi scheme) website. Results: The major category of the generic medicine were antibiotics (53.45%) followed by nonsteroidal anti-inflammatory drugs (10.89%) and cardiovascular (6.93%) drugs. It was evident from the result obtained by comparing the prices across categories that there were both positive and negative deviations. Conclusion: It was very much evident from the results of the mean of differences that even though fixed price contracts being in place, there is a price disparity in the generic drug prices seen under Government Scheme.

AB - Objective: Even though the generic medicines are considered to be a cheaper option compared to the branded medicines in India, there is a need to study the price disparity among the generic medicines. Hence, the present study aims to evaluate the price disparity in generic medicines under Government Scheme in India. Methods: It was found that there were 101 generic medicines approved at a fixed price for procurement under the Central Government Health Services scheme. The prices of these medicines were searched for their availability as well as for current price in Bureau of Pharma PSUs of India (under Jan Aushadhi scheme) website. Results: The major category of the generic medicine were antibiotics (53.45%) followed by nonsteroidal anti-inflammatory drugs (10.89%) and cardiovascular (6.93%) drugs. It was evident from the result obtained by comparing the prices across categories that there were both positive and negative deviations. Conclusion: It was very much evident from the results of the mean of differences that even though fixed price contracts being in place, there is a price disparity in the generic drug prices seen under Government Scheme.

UR - http://www.scopus.com/inward/record.url?scp=85058332036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058332036&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2018.v11i12.28461

DO - 10.22159/ajpcr.2018.v11i12.28461

M3 - Article

AN - SCOPUS:85058332036

VL - 11

SP - 466

EP - 468

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 12

ER -